Overview of age-variations
Age group comparisons |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
27036001 |
Age 29 ± 4, Gender ⚥ |
0.25 (CV (CV=SD of metabolite abundance (peak areas from LC-MS) divided by the mean)) |
LC-MS |
red blood cells, plasma, blood |
27036001 |
Age 81 ± 7, Gender ⚥ |
0.35 (CV (CV=SD of metabolite abundance (peak areas from LC-MS) divided by the mean)) |
LC-MS |
red blood cells, plasma, blood |
18384253 |
Age 24.5 ± 3, Gender ⚥ |
0.72 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
18384253 |
Age 40.8 ± 5.6, Gender ⚥ |
1.03 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
18384253 |
Age 55.6 ± 3.7, Gender ⚥ |
1.35 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
27374292 |
Age [25–35] (median=32), Gender ♂ (Japanese) |
1.075798 (average level of metabolite) |
UHPLC-MS/MS Positive mode |
serum |
27374292 |
Age [55–64] (median=60), Gender ♂ (Japanese) |
1.237545 (average level of metabolite) |
UHPLC-MS/MS Positive mode |
serum |
Linear regression |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
log2 ratio/log2(FC) |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |